Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)
Tamsulosin Hydrochloride Capsule
Product Images NDC 63187-371
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 63187-371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)
This appears to be a figure from a study showing the mean change from baseline in Total AUA Symptom Score (0 to 35) over different durations of treatment in weeks. The study compares the effectiveness of a treatment (2 different doses) and placebo. However, without more context or clearer text, it is difficult to determine specifics of the study or treatment.*
Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)
The text describes a figure labeled "Figure 2B" which shows the mean change from baseline in total AUA symptom score (ranging from 0 to 35) for different treatments. The treatments listed are "0.08mg LNt", "0.4mg", and "Placebo", with the corresponding score changes shown on the graph. The x-axis indicates the duration of treatment in weeks, while the y-axis shows the mean change values. There are also some numbers in parentheses next to each treatment indicating the sample size for each group at different time points.*
Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)
The text describes a figure labeled as 3A showing the mean increase in peak urine flow rate in L/sec for Study 1. The figure includes a graph with a line chart placed on the X-axis representing the duration of treatment in weeks and the Y-axis representing the mean change in mL/sec. The treatment options listed include 0.08mg, 2x 0.4mg, and placebo. However, the text does not provide a clear interpretation of the results or the purpose of the study.*
Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)
This is a graph showing the mean increase in peak urine flow rate (mL/Sec) for Study 2. The x-axis represents the duration of treatment in weeks while the y-axis shows the values of the urine flow rate. The graph shows different treatments denoted by letters and numbers. There is no further information available.*
63187-371-07 (Tamsulosin Fig6)
This is a description of a medication called Tamsulosin HCI 0.4mg, which comes in a bottle of 90 capsules from SNE MASTER. Each capsule contains tamsulosin hydrochloride USP NOC 63187.371.90 and is imprinted with a "D" on its cap and "53" on its body. The product ID is PT037190 and it was made by Aurobindo Pharma Limited in Hyderabad, India. The medication should be stored at 20°C-25°C and kept out of reach of children.*
Chemical Structure (Tamsulosin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
